| NDC Code | 57826-460-02 |
|---|
| Package Description | 250 mL in 1 BAG (57826-460-02) |
|---|
| Product NDC | 57826-460 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Haemonetics Additive Solution Formula 3 (as-3) |
|---|
| Non-Proprietary Name | Citric Acid Monohydrate, Sodium Phosphate, Monobasic, Monohydrate, Sodium Chloride, Adenine, Anhydrous Dextrose, Trisodium Citrate Dihydrate |
|---|
| Dosage Form | SOLUTION |
|---|
| Usage | EXTRACORPOREAL |
|---|
| Start Marketing Date | 20130110 |
|---|
| Marketing Category Name | NDA |
|---|
| Application Number | BN000127 |
|---|
| Manufacturer | Haemonetics Corporation |
|---|
| Substance Name | ADENINE; ANHYDROUS DEXTROSE; CITRIC ACID MONOHYDRATE; SODIUM CHLORIDE; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE; TRISODIUM CITRATE DIHYDRATE |
|---|
| Strength | 3; 100; 4.2; 41; 27.6; 58.8 |
|---|
| Strength Unit | mg/mL; mg/mL; mg/mL; mg/mL; mg/mL; mg/mL |
|---|
| Pharmacy Classes | Acidifying Activity [MoA], Acidifying Activity [MoA], Anti-coagulant [EPC], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE], Decreased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC] |
|---|